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Hepatitis C virus (HCV) nonstructural protein 5A (NS5A) has
been shown to antagonize numerous cellular pathways, including
the antiviral interferon- response. However, the capacity of this
protein to interact with the viral polymerase suggests a more direct
role forNS5A in genome replication. In this study,we employed two
bacterially expressed, soluble derivatives ofNS5A toprobe for novel
functions of this protein.We find thatNS5Ahas the capacity to bind
to the 3-ends of HCV plus andminus strand RNAs. The high affin-
ity binding site for NS5A in the 3-end of plus strand RNAmaps to
the polypyrimidine tract, an element known to be essential for
genome replication and infectivity. NS5A has a preference for sin-
gle-stranded RNA containing stretches of uridine or guanosine.
Values for the equilibrium dissociation constants for high affinity
binding sites were in the 10 nM range. Two-dimensional gel electro-
phoresis followed by Western blotting revealed the presence of
unphosphorylated NS5A in Huh-7 cells stably expressing the sub-
genomic replicon.Moreover, RNA immunoprecipitation andNS5A
pull-down experiments showed the capacity of replicon-derived
NS5A to bind to synthetic RNA and the HCV genome, respectively.
Deletion of all of the casein kinase II phosphorylation sites in NS5A
supported stable replication of a subgenomic replicon in Huh-7.
However, this derivative could not be labeled with inorganic phos-
phate, suggesting that extensive phosphorylation of NS5A is not
required for the replication functions of NS5A. The discovery that
NS5A is anRNA-binding protein defines a new functional target for
development of agents to treat HCV infection and a new structural
class of RNA-binding proteins.
Hepatitis C virus (HCV)2 infection is a global health problem. Most
cases of acute infection lead to chronic infection, which, in turn, pro-
gress to liver cirrhosis and, in the worst cases, liver cancer (1). Current
protocols for treatingHCV infection fail to produce a sustained virolog-
ical response in as much as 46% of treated individuals (1). Clearly, more
effective strategies to treat HCV infection are needed. For many years,
the pursuit of better therapeutics was complicated by the inability to
growHCV in tissue culture and the absence of infectious genomes. The
availability of infectious genomes (2–4) rapidly led to the development
of subgenomic replicons capable of replicating stably in Huh-7 cell lines
and derivatives thereof (5–7).
The subgenomic replicon system has permitted the minimal deter-
minants for genome replication to be determined. Three cis-acting rep-
lication elements exist as follows: 5-nontranslated region (NTR),
3-NTR, and a region locatedwithin the polymerase-coding sequence at
the 3-end of the genome (8–10). In addition, only a subset of the fol-
lowing viral nonstructural proteins is required: NS3, NS4A, NS4B,
NS5A, and NS5B (7). None of the structural proteins are required for
genome replication (7). Among the essential nonstructural proteins, the
most important is NS5B, the viral RNA-dependent RNA polymerase.
NS3 is a bifunctional protein. The amino-terminal domain is a serine
protease responsible for releasing the individual proteins from theNS3-
NS5B polyprotein. The carboxyl-terminal domain is an RNA helicase.
Although many genome replication functions can be envisaged for an
RNA helicase, it is not clear how this activity functions in HCV genome
replication. NS4A is a cofactor for NS3 that binds to the protease
domain andmodulates both the protease and helicase activities (11, 12).
NS4B functions to establish membranous webs in cells that are thought
to be the site of RNA synthesis (13). This function forNS4Bmay require
the NS4AB precursor (14), although interaction between the processed
forms of NS4A and NS4B has been observed (15).
NS5A is essential for genome replication; however, a clear genome
replication function for this protein is not known (16). NS5A interacts
withmembranes in the cell as a result of an amphipathic helix present at
the amino terminus of the protein (Fig. 1). The encoded protein has a
molecular mass of 49 kDa; however, 56- and 58-kDa forms of this pro-
tein have been observed in mammalian cells (17). The 56-kDa form is
thought to arise from phosphorylation of the protein in conserved clus-
ters of serine and threonine residues (clusters II and III in Fig. 1). The
58-kDa form is thought to arise from additional phosphorylation in
cluster I; this form is often referred to as the hyperphosphorylated form.
Formation of the 58-kDa form requires the presence of NS4A and per-
haps a direct interaction between these two proteins (17–19) (Fig. 1).
Recently, NS5A was expressed in bacteria, and this unphosphorylated
form also migrates in SDS-polyacrylamide gels as a 56-kDa species,
suggesting that the proline-rich nature of the protein rather than phos-
phorylation leads to the “aberrant” mobility in gels (20).
To date, most studies of NS5A have illuminated functions for this
protein in resisting the response of cells initiated by interferon-, per-
haps by inhibiting the double-stranded RNA-activated protein kinase
(21). NS5A has the capacity to induce endoplasmic reticulum stress,
resulting in the activation of nuclear factor B (22). NS5A has also been
shown to interact with components of numerous cellular signaling
pathways (16). However, two important observations point to a more
direct role for NS5A in genome replication. First, mutations that
enhance the capacity of subgenomic replicons to replicate RNA in
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Huh-7 cells map to the NS5A-coding sequence, inmany cases changing
a conserved serine in cluster I and reducing or eliminating production of
the 58-kDa form of NS5A (6). In addition, NS5A has been shown to
interact with NS5B, and this interaction is essential for maintenance of
subgenomic replicons in Huh-7 cells (23, 24) (Fig. 1).
We recently succeeded in producing NS5A in bacteria and purifying
soluble forms of this protein suitable for biochemical characterization
(20). In this report, we show that unphosphorylated NS5A has the
capacity to bind to elements located in the 3-ends of HCV plus and
minus strand RNA. This protein binds uridylate- and guanylate-rich,
single-stranded RNA with highest affinity. In addition, we provide evi-
dence that replicon-derived NS5A retains this activity. The observa-
tions reported here have significant implications on roles for NS5A in
regulating the switch from genome translation to genome replication,
recruitment of polymerase and helicase to viral RNA, and enhancement
of polymerase and helicase processivity.
EXPERIMENTAL PROCEDURES
Materials—All RNA oligonucleotides were from Dharmacon
Research, Inc. (Boulder, CO). DNA oligonucleotides for binding assays,
dT15 and dU15C, were fromQiagen. All restriction enzymes, T4 polynu-
cleotide kinase, and Deep Vent DNA polymerase were from New Eng-
land Biolabs, Inc. T4 DNA ligase was from Invitrogen. DNA primers for
PCRs were from Integrated DNA Technologies. [-32P]UTP (6,000
Ci/mmol) was from PerkinElmer Life Sciences; [-32P]ATP (7,000
Ci/mmol) was from ICN. All other reagents were of the highest grade
available from Sigma, Fisher, or VWR Scientific.
Construction of S2204I and 2380–2409 HCV Subgenomic Replicon
Plasmids—Oligo 1 (HCV-5A-4912-PstI-for, 5-GCG CTG CAG ACG
CGT ACA CCA CGG GC-3) and oligo 2 (HCV-5A-5575-BglII-rev,
5-GCG AGA TCT CTC GAG GGA ATT TCC-3) were used to sub-
clone the NS5A-coding sequence from the plasmid pHCVbart.rep1b/
Ava-II into pUC-18 plasmid by using PstI and BglII sites to give pUC18-
NS5A-WT. Oligo 3 (HCV-5A-S2204I-StyI-for, 5-GCG TCT AGA
CCT TGG CCA GCT CAT CAG CTA TCC AGC TGT CTG CGC
CTT-3) and oligo 2 were used to introduce the mutation S2204I into
pUC18-NS5A-WT. The S2204I subclone was digested with BlpI and
XhoI and ligated into BlpI/XhoI-digested pHCVbart.rep1b/Ava-II.
Oligo 4 (HCV-5A-Cluster3-for, 5-GAC GGC GAC GCG GGA
GAG GAG GCT AGT GAG G-3) and oligo 5 (HCV-5A-Cluster3-
rev, 5-CCT CAC TAG CCT CCT CTC CCG CGT CGC CGT C-3)
were used to construct 2380–2409. The overlapping PCR products
were amplified using oligo 6 (HCV-5A-XhoI-for, 5-GCG AAA TTC
CCT CGA GCG ATG CCC ATA-3) and oligo 7 (HCV-MfeI-rev,
5-GCG GGT GGT GTC AAT TGG TGT CTC-3), digested, and
ligated into XhoI/MfeI-digested pHCVbart.rep1b/Ava-II.
Bacterial Expression of Recombinant NS5A—Escherichia coli extract
containing recombinant NS5A was prepared as described previously
(20). Briefly, BL21(DE3)pCG1 cells containing NS5A were grown in 10
ml of NZCYM supplemented with 25 g/ml kanamycin, 20 g/ml
chloramphenicol, and 0.1% dextrose at 37 °C to an A600 of 0.8 before
isopropyl-D-thiogalactopyranoside was added to a final concentration
of 0.5 mM. The cells were grown for an additional 4 h at 20 °C. The
induced cells were analyzed by SDS-PAGE, and the NS5A concentra-
tion was quantitated by densitometric analysis of the Coomassie-
stained gel.
Expression and Purification of NS5A Derivatives—Three NS5A
derivatives, NS5A-His, His--NS5A, and His--NS5A-S2204I, were
expressed in E. coli and purified from the soluble fraction as described
previously (20).
Constructs for in Vitro Transcription—The 5-NTR (terminal 386
nucleotides), 3-NTR (terminal 247 nucleotides), and 3-NTR contain-
ing a deletion of the polypyrimidine tract (3-NTRpoly(U)) were
amplified by PCR from pHCVbart.rep1b/AvaII provided to us by Pro-
fessor Charles Rice (Rockefeller University) (6). The 3-end of the HCV
antigenome (3-TR, terminal 374 nucleotides) was amplified by PCR
from pBRTHCV provided to us by Professor John McCarthy (Univer-
sity of Manchester Institute of Science and Technology, UK) (25). The
amplified products were cloned into a pUC18 vector that contains a
promoter for T7 RNA polymerase, a cloning region, and sequences
encoding a hepatitis  virus ribozyme capable of co-transcriptional
cleavage (26).
In Vitro Transcription Reactions—Plasmid DNA containing sub-
genomicHCV sequences (pHCVbart.rep1b/AvaII) or 3-NTRpoly(U)
was linearized with ScaI and purified by using QIAEX kit (Qiagen). The
poly(rU/C) tract was deleted from subgenomic RNA by linearizing the
transcription templateMfeI. The ()5-NTR plasmid was linearized by
using SacII. Transcription reactions (20l) consisted of 350mMHEPES,
pH 7.5, 32 mM magnesium acetate, 40 mM DTT, 2 mM spermidine, 28
mMNTPs (whereNTPs are amixture of ATP, GTP, UTP, andCTP), 0.5
g of template, and 0.5g of T7 RNA polymerase. For the filter binding
assays, the subgenomic RNA was labeled internally by adding
[-32P]UTP to the in vitro transcription reaction. Reactions were incu-
bated for 3 h at 37 °C. Magnesium pyrophosphate was removed by cen-
trifugation. RQ1DNase (Promega) was added to remove the DNA tem-
plate. RNA was precipitated by using lithium chloride. The RNA pellet
was suspended in TE and desalted by using a 1-ml Sephadex G-25
(Sigma) spin column. RNA concentration was determined by using
absorbance at 260 nm and an extinction coefficient of 85.9 M1 cm1
for subgenomic RNA, 68.6 M1 cm1 for the subgenomic RNAwith a
poly(rU/C) tract deletion, 4.10 M1 cm1 for ()5-NTR RNA, and
1.55 M1 cm1 for the ()3-NTR poly(U) RNA.
The ()3-NTR and ()3-TR were prepared by in vitro transcrip-
tion of the EcoRI-digested plasmids described above. RNA with a free
5-OH was produced by supplementing the transcription reaction with
guanosine. The final transcription reaction contained the following: 25
ng/l digested DNA, 60 mM HEPES, pH 7.5, 40 mM DTT, 2 mM sper-
midine, 25 mMmagnesium acetate, 8 mM guanosine, 2.6 mM each NTP,
and 25 g of T7 RNA polymerase. Uridine comprises 45% of the ()3-
NTR sequence. For this RNA, transcription proceeded more efficiently
by increasing the UTP concentration to 5.2 mM. Reactions were incu-
bated for 2 h at 37 °C, followed by digestion with RQ1DNase (1 unit/g
DNA template) for 30min at 37 °C. After phenol/chloroform extraction
and ethanol precipitation, the transcripts were gel-purified on a 5%
denaturing polyacrylamide gel containing 3.5 M urea and 50% formam-
ide for ()3-NTR and 5% denaturing polyacrylamide gel with 7 M urea
for ()3-TR. The RNA was extracted from the gel by using an Elutrap
(Schleicher & Schuell) and concentrated by ethanol precipitation. RNA
concentration was determined by using absorbance at 260 nm and
FIGURE 1. Functional domains of HCV NS5A. The amino-terminal 32 amino acids form
an amphipathic helix that is responsible for interaction of NS5A with membranes (27).
NS5A has three clusters of conserved serines (I, 2194 –2210; II, 2246 –2269; and III, 2380 –
2409) that can be phosphorylated (16). The asterisk indicates the site of the S2204I adapt-
ive mutation. Phosphorylation within cluster I requires expression of NS4A and poten-
tially an interaction with residues 2135–2139 of NS5A (17). NS5A (residues 2077–2134
and 2249 –2306) has been to shown to interact functionally and physically with the viral
RNA-dependent RNA polymerase, NS5B (23).
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extinction coefficients of 2.63 and 3.98 M1 cm1 for the ()3-NTR
and ()3-TR, respectively. The 5-OH-containing RNAs were radiola-
beled with [-32P]ATP and T4 polynucleotide kinase.
Purification and Trace Labeling of RNA Oligonucleotides—The syn-
thetic RNA oligonucleotides were purified on a 23% denaturing poly-
acrylamide gel. Labeling reactions, typically 20 l, contained 0.1 M
[-32P]ATP, 10 M RNA, 1 kinase buffer, and 0.4 units/l T4 polynu-
cleotide kinase. Reactions were incubated 1–2 h at 37 °C and stopped by
incubating for 15min at 65 °C.Unincorporated nucleotidewas removed
by passing through a 1-ml Sephadex G-25 spin column. The absence of
labeled nucleotide contamination was verified by thin layer chromatog-
raphy followed by PhosphorImaging. The integrity of the labeled RNA
was verified by denaturing PAGE followed by PhosphorImaging.
RNA Filter Binding Assays—Binding reactions, typically 50 l, con-
tained 2 nM radiolabeled RNA (2 nM) and NS5A (0–500 nM) in binding
buffer (50mMHEPES, pH 7.5, 5mMmagnesium chloride, 10mMBME).
The binding reaction was initiated by addition of the diluted NS5A to
the remaining components. Reactions were incubated on ice for 30min.
Membranes were pre-soaked in the binding reaction buffer and assem-
bled from top to bottom as follows: polysulfone (Pall Scientific), nitro-
cellulose (Schleicher & Schuell), and Hybond-N nylon (Amersham
Biosciences), in a slot-blot apparatus (Amersham Biosciences). After
assembly, 20 l of each binding reaction was applied to each slot and
filtered through the membranes. Membranes were air-dried and visu-
alized by PhosphorImaging (Amersham Biosciences) and quantified by
using ImageQuant software (Amersham Biosciences). Binding data
were fit to the following hyperbolic Equation 1,
  maxP/	P 	 K0.5
 (Eq. 1)
where  is the percentage of bound RNA; max is the maximal percent-
age of RNA competent for binding; [P] is the concentration of NS5A;
and K0.5 is the apparent dissociation constant. Fitting was performed by
using KaleidaGraph 3.5 software (Synergy Software). In one case, the






where n is the Hill coefficient, and the other variables are as described
above.
UV Cross-linking Assay—In a typical UV cross-linking experiment,
radiolabeled rU15 (100 nM) was incubated with NS5A (0–500 nM) in
binding buffer (50 mM HEPES, pH 7.5, 10 mM BME, 5 mM magnesium
chloride) for 30 min on ice and then irradiated with 254 nm light for 15
min at 4 °C. Proteinase K digestion reaction employed 14 g of protein-
ase K incubated with the cross-linked sample for 2 h at 50 °C. Each
cross-linked sample wasmixedwith an equal volume of 2 SDS loading
buffer, heated for 3 min at 65 °C prior to loading on an 8% SDS-poly-
acrylamide gel. After electrophoresis, the gel was fixed, and cross-linked
species were visualized by PhosphorImaging.
Fluorescence Polarization Assay—Experiments were performed by
using a Beacon fluorescence polarization system (Amersham Bio-
sciences). NS5A (0–100 nM) and 3-fluorescein-labeled rU20 (FL-rU20)
were gently mixed in binding reaction buffer (50 mMHEPES, pH 7.5, 50
M EDTA, 0.1 mg/ml bovine serum albumin, and 10 mM NaCl) and
incubated for 3 min at 37 °C. Binding of NS5A was measured by the
change in polarization. All steps were performed in reduced light. Data
were fit to a hyperbola by using KaleidaGraph.
Cell Culture and G418 selection of HCV Subgenomic Replicons—Huh-7
cells were maintained in Dulbecco’s modified Eagle’s medium supple-
mented with 10% fetal bovine serum (Invitrogen), 100 units/ml peni-
cillin/streptomycin (Invitrogen), and 0.1 mM nonessential amino acids
(Invitrogen).
To select for subgenomic replicons that can stably replicate in Huh-7
cells, 1.6  106 Huh-7 cells were transfected with 2 g of in vitro tran-
scribed replicon RNA using TransMessenger transfection system (Qia-
gen), and 1  105 cells were seeded in 100-mm diameter dishes. 12–14
h post-transfection, the cells were placed under G418 selection (500
g/ml) for 2–3 weeks. Colonies were stained with crystal violet. S2204I
and pol subgenomic replicons served as positive control and negative
control, respectively.
Two-dimensional Gel Electrophoresis and Western Blot Analysis—Iso-
electric focusing (IEF) of the NS5A samples was performed using Zoom
IPGRunner system(Invitrogen) andZoomstrips, pH4–7 (Invitrogen).Cell
lysates for two-dimensional analysis were prepared as described in the
manufacturer’s protocol with some modification. E. coli cells expressing 5
g of NS5A, 1.3  107 Huh-7 parental cells, or cells stably expressing the
S2204I HCV repliconwere lysed by sonication in 950l of lysis buffer (1
Zoom two-dimensional protein solubilizer (Invitrogen), 3mMTris base, 21
mM DTT, supplemented with protease inhibitor mixture (Roche Applied
Science)). Fivel of 99%N,N-dimethylacrylamide was added to the lysates
for alkylation and incubated for 30min on ice, followed by 15min of incu-
bation at room temperature. Ten l of 2 M DTTwas added to quench any
excess N,N-dimethylacrylamide, and the lysates were centrifuged at
16,000  g for 20 min at 4 °C. The supernatants were collected, and the
protein concentrations were measured by the Bradford assay. For isoelec-
tric focusing electrophoresis, 10 l of the prepared lysates were diluted in
1.1Zoom two-dimensional protein solubilizer, 10mMDTT, 1% pH 4–7
Zoom carrier ampholytes (Invitrogen), and 0.02% bromphenol blue to a
final volume of 140 l. A Zoom strip, pH 4–7, was hydrated with each
sample for1hat roomtemperature. IEFwasperformedat200V for20min,
450 V for 15min, 750 V for 15min, and 2000 V for 105min. After IEF, the
strips were equilibrated in 1 NuPAGE LDS Sample buffer/1 Reducing
Agent (Invitrogen) at room temperature for 15min on a rotary shaker. The
equilibrated strips were applied to 8% SDS-polyacrylamide gel and electro-
phoresed with the purified recombinant His--NS5A as themarker. After
electrophoresis, proteins were transferred to nitrocellulosemembrane and
probed by rabbit polyclonal anti-NS5A antibody as described previously
(20).
To reprobe themembrane tomousemonoclonal anti-phosphoserine
antibody (Sigma), themembranewas strippedwith stripping buffer (100
mM 2-mercaptoethanol, 2% SDS, 62.5 mM Tris-HCl, pH 6.7) and incu-
bated at 50 °C for 30 min. Membrane was subsequently washed and
probed with 1:1000 dilution of the anti-phosphoserine antibody and
1:1000 dilution of goat anti-mouse IgG-horseradish peroxidase (Santa
Cruz Biotechnology). The proteins containing phosphoserine were
detected by ECL Western blot detection reagents (Amersham Bio-
sciences) and exposed to a BioMax MR x-ray film (Eastman Kodak).
UV Cross-linking and Immunoprecipitation of Huh-7 Cell Lysates
with RNA—1.0 107 parental Huh-7 cells or S2204I replicon cells from
T-75 flasks were trypsinized and washed with phosphate-buffered
saline (PBS). Cells were suspended in 200l of hypotonic buffer (10mM
HEPES, pH 7.5, 10mMKCl, 1.5mMMgCl2, supplementedwith protease
inhibitor mixture) on ice and lysed by the addition of 25 l of hypotonic
buffer containing 2.5% Nonidet P-40. The samples were freeze-thawed
five times in liquid nitrogen and centrifuged at 16,000  g for 30 min.
Protein was divided into 250-g aliquots and stored at 80 °C.
Synthetic rU7 with 4-thio modification on the fourth uracil (4-S-rU7)
was end-labeled with [-32P]ATP and used in the cell lysate UV cross-
linking experiments. 1 M of the radiolabeled 4-S-rU7 was incubated
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with 250 g (50 l) of the Huh-7 cell lysates on ice for 30 min and then
irradiated at 302 nm for 5 min at 4 °C. The samples were diluted with
200 l of the HNAET buffer (50 mM HEPES, pH 7.5, 150 mM NaCl,
0.67% bovine serum albumin, 1 mM EDTA, 0.33% Triton X-100) and
pre-cleared by incubating with 50 l of the pre-washed Pansorbin cells
(Calbiochem) for 1 h at 4 °C on a rotary shaker. The supernatant was
then incubated with 4 l of the rabbit polyclonal anti-NS5A antibody
overnight at 4 °C. 50 l of the pre-washed Pansorbin cells were added
and incubated for 2 h at 4 °C. The cell pellets were washed three times
with 0.5ml ofHNAETS buffer (HNAET containing 0.5% SDS), followed
by 0.5ml of HNE buffer (50mMHEPES, pH 7.5, 150mMNaCl and 1mM
EDTA). Each cell pellet was suspended in 40l of 1 SDS sample buffer
(112.5 mM Tris, pH 6.8, 2.5% SDS, 25% glycerol, 2.5% BME, and 0.025%
bromphenol blue) and incubated at 90 °C for 10min. The proteins were
resolved on 8% SDS-polyacrylamide gels, and the gels were fixed and
dried for PhosphorImaging analysis.
NS5A Pull-down Assay—Biotinylated HCV replicon RNA was pre-
pared by in vitro transcription using T7 RNA polymerase. Typically, a
20-l transcription reaction contains 0.5 g of ScaI-linearized pHCV-
Luc-WT plasmid DNA, 350 mM HEPES, pH 7.5, 32 mM MgCl2, 40 mM
DTT, 2 mM spermidine, 28 mM NTPs, 50 M Biotin-11-CTP
(PerkinElmer), and 0.5 g of T7 RNA polymerase.
To prepare cell lysates for the pull-down assay, 3 107Huh-7 cells or
S2204I replicon cells were suspended in 1 ml of cold hypotonic buffer
(10 mM Tris-HCl, pH 7.8, 10 mM NaCl) and lysed by a Dounce homog-
enizer. The lysate was centrifuged at 900  g for 5 min, and the S9
fraction was kept at 80 °C. In the pull-down experiments, 2 g of
biotinylated HCV replicon RNA was mixed with 50 l of streptavidin
magnetic beads (New England Biolabs) and incubated at room temper-
ature for 30 min. 250 g (70 l) of cell lysate and 100 g (10 l) of
tRNA were added to the beads and incubated on ice for 30 min. The
beadswere pulled down by amagnet, and the supernatant was removed.
After three washes with 100 l of hypotonic buffer, the beads were
suspended in 1 SDS sample buffer and heated at 95 °C for 10min prior
to 8% SDS-PAGE separation and Western blot analysis.
Formaldehyde Cross-linking of NS5A-HCV RNAComplexes—2 g of
the in vitro transcribed biotinylated HCV replicon RNA was added to
125 g of cell lysate supplemented with 100 g of tRNA, and the mix-
ture was incubated on ice for 30 min. Cross-linking was initiated by
adding 16% formaldehyde (Polysciences, Warrington, PA) to 1% final
concentration. After incubation at room temperature for 15 min, the
reaction was quenched by the addition of 0.25 M glycine (final concen-
tration) followed by a 5-min incubation at room temperature. 50 l of
the streptavidin magnetic beads were added to the quenched sample
and incubated at room temperature for 30 min. The beads were pulled
down by a magnet, and the supernatant was removed. After three strin-
gent washes with 100 l of HNAETS buffer and two washes with 100 l
of hypotonic buffer, the beads were suspended in 50 l of hypotonic
buffer, and 1 l (32.5 mg/ml, Sigma) of RNase A was added to the
suspension. The ribonuclease treatment was allowed to go for 30min at
room temperature. After adding 50 l of 2 SDS sample buffer, the
sample was heated at 95 °C for 10min, and the solubilized proteins were
analyzed by 8% SDS-PAGE and Western blotting.
Metabolic Labeling of Proteins—S2204I or 2380–2409 stable cells
were incubated in methionine- and cysteine-deficient Dulbecco’s mod-
ified Eagle’s medium (Invitrogen) or phosphate-deficient Dulbecco’s
modified Eagle’smedium (Invitrogen) for 6 h before Express 35S-protein
labeling mix (200 Ci/ml; PerkinElmer Life Sciences) or
[32P]orthophosphate (250 Ci/ml; PerkinElmer Life Sciences) was
added. After an 18-h incubation, cells were washed twice with cold PBS
and lysed with SDS lysis buffer (50 mM Tris-Cl, pH 7.6, 0.5% SDS, 1 mM
EDTA, 20 g/ml of phenylmethylsulfonyl fluoride). The cell lysates
were passed through a 27-gauge needle several times to shear cellular
DNA. After a 10-min incubation at 75 °C, the lysates were clarified by
centrifugation. Immunoprecipitation was performed as described
above.
RESULTS
HCV NS5A Binds to HCV Subgenomic Replicon RNA
We have described the expression and purification of two soluble
derivatives of HCVNS5A that were suitable for biochemical character-
ization (20). The first derivative, NS5A-His, consists of the full-length
NS5A protein containing a carboxyl-terminal hexahistidine tag. The
second derivative, His--NS5A, contains an amino-terminal hexahisti-
dine tag in place of the first 32 amino acids of wild-type NS5A that have
been implicated in membrane binding (27). Although results presented
in this report employed themore solubleHis--NS5Aderivative, essen-
tially identical results were obtained with the full-length protein. The
purity of NS5A-His and His--NS5A is shown in Fig. 2.
During development of the purification procedures for the NS5A
derivatives, we noted that removal of nucleic acid from the extract was
essential in order to observe reproducible binding of NS5A to various
ion-exchange and affinity resins (20). The capacity of nucleic acid to
interfere with NS5A binding to chromatography resins suggested the
possibility that NS5A was a nucleic acid-binding protein. This possibil-
ity was tested directly by using a filter binding assay (28, 29). His--
NS5A (0–500 nM) was mixed with labeled HCV subgenomic replicon
RNA (1 nM). The binding reactionwas incubated on ice for 30min prior
to separating free RNA from NS5A-bound RNA. Binding reactions
were loaded into a slot-blot apparatus containing three membranes:
polysulfone, nitrocellulose, and nylon. The polysulfone membrane
retains any large protein-RNA aggregates. The nitrocellulose mem-
brane retains the soluble protein-RNA complexes. The nylon mem-
brane retains any free RNA, permitting more accurate quantitation. As
the concentration of His--NS5A increased, more His--NS5A-RNA
complex was retained on the nitrocellulose membrane (Fig. 3A). Very
few, if any, large aggregates formed given the minimal retention of label
on the polysulfonemembrane (Fig. 3A). The fraction of RNAboundwas
plotted as a function of [His--NS5A], and the data were fit to an equa-
tion describing a hyperbola (Eq. 1), yielding a K0.5 value of 320  25 nM
(Fig. 3B). An NS5A derivative containing the S2204I change functioned
as well as wild-type NS5A (Fig. 3B). This change enhances stable repli-
cation ofHCV subgenomic replicons (6).When the 3-NTRwas deleted
from the subgenomic RNA, there was an apparent loss of high affinity
binding sites (Fig. 3C).
FIGURE 2. Purified proteins employed in this study. NS5A-His (600 ng) and His--NS5A
(600 ng) were resolved by SDS-PAGE by using a 4 –15% gradient gel.
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HCV NS5A Binds to the 3-Ends of HCV Plus and Minus Strand RNA
In order to begin to delimit the sites onHCVRNAbound byNS5A, in
vitro transcripts representing the 3-ends of HCV plus (3-NTR) and
minus strand (3-TR) RNAs were evaluated. Because the 3-ends of
HCV plus and minus strand RNAs are thought to be the sites for initi-
ation of RNA synthesis, binding of NS5A to these regions of HCVRNAs
would support a role for the RNA binding activity of NS5A in genome
replication. The analysis was performed as described above, and the
quantitation is shown in Fig. 4. His--NS5A bound to both the 3-NTR
and 3-TR with similar affinity, K0.5 values of 80  10 and 130  20 nM,
respectively (Fig. 4A). Although the extrapolated end point of the bind-
ing reaction for 3-NTR was 80  4%, the extrapolated end point of the
binding reaction for 3-TR was only 40  3%. These data suggest that
the sites to which NS5A binds on the 3-TR are not accessible in every
molecule of RNA present in the population.
Molecular genetic studies of the HCV 3-NTR have shown that two
elements of the RNAare absolutely essential for genome replication: the
polypyrimidine tract and the terminal 98 nucleotides, commonly
referred to as the 3-X tail (9, 10, 30). Deletion of the polypyrimidine
tract reduced substantially the capacity of NS5A to bind to this RNA
(Fig. 4A).
Finally, an experiment was performed to determine whether NS5A
would bind to the 5-NTR. As shown in Fig. 4B, NS5A binds to this
element. However, the affinity of the interaction is reduced substantially
relative to NS5A binding to the 3-NTR. In addition, a good fit of the
data required a cooperative binding model (Eq. 2), suggesting that mul-
tiple molecules of NS5A may be required to form a stable NS5A-5-
NTR complex.
NS5A Binds to Uridylate- and Guanylate-rich RNA
In order to begin to define the sequence specificity, if any, for NS5A,
we evaluated the capacity of His--NS5A to bind to a series of oligonu-
cleotides: rU15, rG15, rA15, rC15, (UAG)5 (representative of a single-
stranded, heteropolymeric RNA), and the terminal 20 nucleotides from
the 3-NTR (referred to as t3-NTR) that folds into a hairpin (represent-
ative of double-stranded, heteropolymeric RNA). His--NS5A was
capable of binding both rU15 and rG15 with high affinity (K0.5 values of
50 5 and 15 5 nM, respectively) (TABLEONE).His--NS5Adid not
bind to any of the other RNAs tested (TABLE ONE), suggesting that
NS5A binds single-stranded stretches of uridylate- and/or guanylate-
FIGURE 3. NS5A binds to HCV subgenomic replicon RNA. Interaction between NS5A
and subgenomic RNA was monitored by using a filter binding assay. Radiolabeled RNA (1
nM) was incubated with His--NS5A (0 –500 nM), loaded onto a slot-blot apparatus, and
filtered through the following three membranes: polysulfone, nitrocellulose, and nylon
(top to bottom). A, RNA bound to each membrane as a function of NS5A concentration
visualized by PhosphorImaging. B, quantitation of the data shown in A yielded a percent-
age of RNA bound that was plotted as a function of NS5A concentration and fit to Equa-
tion 1. Both wild-type (WT) His--NS5A (●) and the S2204I (SI) derivatives (E) were eval-
uated. The K0.5 value of 320  25 nM is for both. C, an RNA derivative with a deletion of the
poly(rU/C) tract in the subgenomic RNA (Œ) did not contain the high affinity sites
observed in the wild-type RNA (●). The inset expands the initial portion of the graph.
FIGURE 4. NS5A binds to the 3-ends of HCV plus and minus strand RNAs. A, interac-
tion between NS5A and the three 3 RNAs was monitored, quantitated, and fit as
described in the legend to Fig. 3. The K0.5 values are 80  10, 130  20, and 400  50 nM
for the ()3-NTR (●), ()3-TR (f), and ()3-NTRpoly(U) (E), respectively. The end
point for the ()3-TR was 40  3%, suggesting that all of the sites in this RNA are not as
accessible as those in the ()3-NTR. B, interaction between NS5A and the 5-NTR was fit
best by a cooperative binding model (Equation 2 under “Experimental Procedures”) with
the following parameters: n  2.3  0.2, K0.5  73  4 nM, and an end point of 64  2 nM.
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containing RNA. Increasing the length of oligo(rU) from 15 to 30 nucle-
otides did not increase the affinity ofHis--NS5A for this RNA (TABLE
ONE), suggesting that the His--NS5A RNA-binding-site size is no
greater than 15 nucleotides.
In order to confirm that the inability to observe binding of His--
NS5A to rC15 was not due to the limited sensitivity of the direct filter
binding assay, we performed a competition experiment. His--NS5A
(80 nM) and labeled rU15 (2 nM) were mixed with increasing concentra-
tions of rC15 (0–200 nM), and the fraction of His--NS5A-rU15 com-
plex remaining was determined and plotted as function of rC15 concen-
tration (Fig. 5). Again, neither rC15 (Fig. 5) nor rA15 (data not shown)
was capable of competing effectively with rU15. Competition by rC15
was not observed evenwhen the concentrationwas increased to 800 nM.
Control experiments showed that unlabeled rU15 competed quite well
for the labeled rU15 (Fig. 5). We also used this approach to evaluate
whether His--NS5A could bind dT15 or dU15. Binding to dU15 was
120-fold weaker than rU15 binding (Fig. 5); binding to dT15 was not
observed (Fig. 5). Together, these data suggestNS5A interacts with both
the sugar and base of the bound nucleic acid.
Cross-linking of His--NS5A to rU15
Multiple attemptsweremade to interrogate theNS5A-RNAcomplex
by using a native gel mobility shift assay. Unfortunately, these attempts
were not successful. Therefore, in order to provide some physical evi-
dence for the association of NS5A with RNA and to obtain information
on the stoichiometry of binding, we performed a UV cross-linking
experiment. His--NS5A (0–500 nM) was incubated with labeled rU15
(100 nM) for 30min prior to exposing themixture to 254 nm light for 15
min. Cross-linked products were resolved by SDS-PAGE and visualized
by PhosphorImaging (Fig. 6A). His--NS5A cross-linked to rU15, and
the cross-linking was concentration-dependent (Fig. 6A). The fastest
migrating species was consistent with a 1:1 stoichiometry of His--
NS5A:rU15. A slower migrating species was also observed that was con-
sistent with two molecules of His--NS5A bound to rU15, suggesting
that less than 10 nucleotides are required for NS5A binding to RNA.
The specificity of the cross-linking was confirmed by showing that the
cross-linked complexes could be competed away by using unlabeled
rU15 but not by using unlabeled rC15 (Fig. 6B).
Determination of the Equilibrium Dissociation Constant for
His--NS5A Binding to rU20
Because the filter binding approach is a nonequilibrium method,
apparent dissociation constants (K0.5) obtained by using this approach
may not accurately reflect the true equilibrium dissociation constant
(Kd). In order to obtain a trueKd value for theHis--NS5A-rU complex,
we turned to a fluorescence polarization assay. In this assay, protein is
mixed with a fluorescein-conjugated nucleic acid, and complex forma-
tion is detected as an increase in anisotropy of the emitted light. His--
NS5A (0–168 nM)was incubatedwith fluorescein-labeled rU20 (0.1 nM).
The change in anisotropy was plotted as a function of the concentration
ofHis--NS5A. The datawere fit to an equation describing a hyperbola,
yielding aKd value of 10 2 nM (Fig. 7). ThisKd value is actually in good
agreement with the K0.5 value obtained by using the filter binding
approach.
Unphosphorylated NS5A in Huh-7 Cells Replicating a Subgenomic
Replicon
The protein evaluated in this study was not phosphorylated. Inmam-
malian cells, NS5A has been shown to be phosphorylated (6, 31). In
order to determine whether unphosphorylated NS5A is present in
Huh-7 cells replicating a subgenomic replicon, we prepared extracts,
resolved proteins by two-dimensional gel electrophoresis, and detected
the various forms of NS5A by Western blotting (Fig. 8A). The replicon
employed contained the S2204I mutation and is referred to as the SI
replicon. Forms of NS5A with pI values of 4.5, 5.0 and 6.5 were
observed (Fig. 8A). The form with a pI value of 5.0 is clearly phospho-
rylated as this region of the blot stained with an anti-phosphoserine
antibody (Fig. 8B). That the proteins detected by using antibodies
against NS5A and phosphoserine are indeed NS5A was confirmed by
evaluating extracts prepared from Huh-7 cells (Fig. 8, C and D). Forms
of NS5A with pI values of 4.5 and 6.5 were not detected by the anti-
phosphoserine antibody (compare Fig. 8, A to B). The more acidic form
may arise from threonine phosphorylation. However, the more neutral
form was the most likely candidate for unphosphorylated NS5A. In
order to determine the pI for unphosphorylated NS5A, we evaluated
extracts prepared from E. coli expressing full-lengthNS5A. As shown in
Fig. 8E, the pI value for the unphosphorylated protein is in the 6.5 range.
That this protein was unphosphorylated was confirmed by the absence
of reactivity with the anti-phosphoserine antibody (Fig. 8F). Taken
together, these data demonstrate the existence of unphosphorylated,
processed NS5A at steady state in Huh-7 cells stably replicating a HCV
subgenomic replicon.
Replicon-derived NS5A Binds to RNA
Binding to rU7—The presence of unphosphorylated protein inHuh-7
cells replicating HCV RNA does not prove that this protein is compe-
tent for RNA binding. Indeed, the presence of the other HCV nonstruc-
tural proteins could preclude interaction ofNS5Awith RNA. In order to
TABLE ONE
NS5A is a G/U-rich RNA-binding protein
RNA binding to the indicated RNAs was evaluated by using a filter-binding
assay as described under “Experimental Procedures.”
RNA employed Binding parameters
K0.5 End point
nM %
rU15 50  5 90  5





rU30 70  5 100  5
FIGURE 5. NS5A interacts with both the base and the sugar of bound nucleic acid.
Using the filter binding assay in a direct mode is not always sensitive enough to detect
weak binding. Therefore, investigation of the binding specificity of NS5A employed a
competitive assay. Competitor RNA or DNA oligonucleotides (0 –200 nM) (rU15 (Œ), rC15
(E), dU15C (●), or dT 15 (f)) were mixed with 2 nM radiolabeled rU15 prior to the addition
of 80 nM His--NS5A. The samples were evaluated as described in the legend to Fig. 3.
Shown is the percentage of radiolabeled rU15-NS5A complex formed as a function of
competitor oligonucleotide.
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demonstrate RNA binding activity for NS5A derived from Huh-7 cells
stably replicating HCV subgenomic RNA, we performed an RNA
immunoprecipitation experiment. Briefly, extracts were prepared,
mixed with end-labeled rU7 containing 4-thiouridine at position 4, and
exposed to 302 nm light. NS5Awas immunoprecipitated; proteins were
resolved by SDS-PAGE, and the dried gel was exposed to a Phospho-
rImaging screen. NS5A was cross-linked to the labeled oligonucleotide
(Fig. 9A, lane  SI replicon). The size of the cross-linked species was in
the 60-kDa range, consistent with a single molecule of NS5A (56 kDa)
bound to a single oligonucleotide (2.3 kDa). Cross-linked cellular pro-
teins were not present in this region of the gel (Fig. 9A, lane Huh-7),
confirming the specificity of the protocol.We conclude that NS5A pro-
duced in Huh-7 cells is a single-stranded RNA-binding protein capable
of binding to U-rich RNA.
Binding to HCV Genome—Given the existence of a poly(U) tract in
the 3-end of HCV genomic RNA, it is reasonable to conclude that the
Huh-7 cell-derived NS5Awill bind to this RNA. However, other NS5A-
binding sites may exist in genomic RNA. In order to ask this question,
we developed an NS5A pull-down experiment. HCV RNA was synthe-
sized in vitro in the presence of biotinylated CTP. Under the transcrip-
tion conditions employed, one to four biotinylated cytidine residues
should have been incorporated into HCV genomic RNA. The transla-
tional efficiency and specific infectivity of this RNAwas within 2-fold of
unmodified RNA (data not shown). Biotinylated RNA was mixed with
cell lysate, and complexeswere pulled downby using streptavidin beads.
Bound protein was eluted from the beads by using SDS, and the pres-
ence of NS5A was determined by Western blotting after SDS-PAGE.
NS5Awas not observed inHuh-7 cells (Fig. 9B, lane 1). However, NS5A
was observed when the intact genome was employed (Fig. 9B, lane 2).
Deletion of the 3-NTR did not prevent NS5A binding (Fig. 9B, lane 3),
suggesting that the polypyrimidine tract is not the only site on HCV
RNA towhichNS5A binds. NS5A recovery from the replicon lysate was
dependent upon RNA as NS5A was not recovered when biotinylated
DNA was employed (data not shown).
Although the NS5A pull-down experiment confirms that NS5A
binds to HCV RNA, this experiment does not provide any information
on whether or not the binding is direct. In order to obtain evidence for
direct binding, we performed the following experiment. Lysates con-
tainingNS5A (Fig. 9C, lane 1) were used to form complexes as described
above (Fig. 9C, lane 3). Washing the beads under very stringent condi-
tions released NS5A from the beads (Fig. 9C, lane 4). If the complexes
were cross-linked by using formaldehyde, then NS5A recovery was
resistant to stringent washing and required digestion of the RNA by
RNase A (Fig. 9C, lane 2 and data not shown). If the interaction of NS5A
was mediated by a protein factor, then retention by cross-linking would
require anNS5A-protein cross-link that would preclude the observance
FIGURE 6. NS5A cross-links to RNA. A, cross-linking in the absence of competitor. Radiolabeled rU15 (100 nM) was incubated with an increasing amount of His--NS5A (0 –500 nM)
prior to exposure to 254 nm light. Shown is the PhosphorImager of the cross-linked products resolved by SDS-PAGE on an 8% gel. The PK lane is a cross-linking reaction containing
500 nM NS5A that was treated with proteinase K prior to SDS-PAGE (see “Experimental Procedures”). B, cross-linking in the presence of competitor. In order to show the specificity of
cross-linking, experiments were performed in the presence of the indicated concentrations of rU15 or rC15.
FIGURE 7. Binding of NS5A to RNA measured by using a fluorescence polarization
assay. His--NS5A (0 –100 nM) was incubated with a fluorescein-labeled rU20 (0.1 nM)
and the fluorescence polarization (mP) was measured by using a Beacon fluorescence
polarization instrument. The change in fluorescence polarization was plotted as a func-
tion of His--NS5A concentration and fit to a hyperbola by using KaleidaGraph, yielding
a Kd value of 10  2 nM.
FIGURE 8. Unphosphorylated NS5A protein exists in Huh-7 cells expressing the
S2204I subgenomic replicon. Huh-7 cells stably expressing the S2204I (SI) HCV sub-
genomic replicon were lysed as described under “Experimental Procedures,” and the
sample was subjected to two-dimensional gel electrophoresis and Western blot analysis.
Parental Huh-7 cells and E. coli cells expressing recombinant NS5A were used as controls.
Lysate prepared from the SI replicon cells was probed by using a rabbit polyclonal anti-
NS5A antibody (A) and by a mouse monoclonal anti-phosphoserine antibody (B). NS5A
spots were detected across the entire ranges; the phosphorylated NS5A species is cen-
tered around pH 5.0. Reactivity with anti-NS5A antibody was absent in the parental
Huh-7 cell sample (C). The background phosphoserine containing proteins in the Huh-7
cells can be seen in D. The spots for the bacterially expressed unphosphorylated NS5A
centered around pH 6.5 (E), and no phosphorylated NS5A was detected in this sample (F).
M indicates the marker lane, where the purified recombinant His--NS5A was loaded.
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of appropriately sized NS5A. Therefore, we conclude that binding of
replicon-derived NS5A to HCV RNA is mediated by a direct binding of
the protein to RNA.
Primary Sites for NS5A Phosphorylation Are Dispensable for RNA
Replication in Huh-7 Cells and RNA Binding in Vitro
A second approach that we took to evaluate the potential role of
NS5A phosphorylation in RNA binding was to engineer a replicon that
expressed anNS5Amutant incapable of being phosphorylated by casein
kinase II. We and others (20, 31) have shown that casein kinase II is
responsible for most of the observed phosphorylation of NS5A and that
these sites are restricted to a carboxyl-terminal domain of NS5A
referred to as cluster III (Fig. 10A). We deleted residues 2380–2409 in
cluster III in the background of the S2204I adaptive mutation. This
mutant was capable of stable replication in Huh-7 cells (Fig. 10B, panel
SI,2380–2409). Western blotting confirmed the expression of the
truncated NS5A derivative (Fig. 10C, lane SI,2380–2409). Although
both wild-type NS5A (SI) and the deletion mutant (SI,2380–2409)
were efficiently labeled with [35S]methionine and -cysteine (Fig. 10D,
panel 35S), only the wild-type protein was labeled with [32P]orthophos-
phate (Fig. 10D, panel 32P). The S2204I mutation is known to prevent
formation of the p58 formofNS5A, i.e. phosphorylation in cluster I (Fig.
10A) (31). Together, these studies suggest that extensive phosphoryla-
tion of NS5A is not required for the replication functions of NS5A.
DISCUSSION
NS5A Is a Single-stranded-RNA-binding Protein with Specificity for
Uridylate- and Guanylate-rich RNA—HCV NS5A has been implicated
in interactions with myriad cellular proteins (16, 21, 32). However, a
more direct role in genome replication has been suggested by the find-
ing that NS5A interacts in solution with NS5B, the viral RNA-depend-
ent RNA polymerase (23). In order to begin to employ a biochemical
approach to sort out the various functions of NS5A, we developed a
FIGURE 9. Replicon-derived NS5A binds RNA. A, cross-linking to rU7. The parental
Huh-7 cells and SI replicon cells were lysed as described under the “Experimental Proce-
dures.” 250 g (50 l) of the total protein was incubated with 1 M radiolabeled 4-S-rU7
on ice for 30 min. After UV cross-linking at 302 nm for 5 min, the NS5A protein was
immunoprecipitated using a rabbit polyclonal anti-NS5A antibody and Pansorbin cells.
The immunoprecipitated complexes were analyzed by 8% SDS-PAGE and PhosphorIm-
aging. A predominant NS5A cross-linked species was detected in the SI replicon sample.
No band in that molecular range was present in the Huh-7 parental cells. B, binding to
HCV genome. Biotinylated HCV replicon RNA (2 g) was incubated with 250 g of cell
lysate. Streptavidin beads (50 l) were added to pull down the RNA-protein complex.
The samples were heated in 1 SDS sample buffer and analyzed by 8% SDS-PAGE and
Western blotting. NS5A was detected when S2204I replicon cell lysate was incubated
with the biotinylated HCV RNA (lane 2). Deletion of the 3-untranslated region from the
HCV replicon RNA did not reduce binding significantly (lane 3). Pull-down experiment
with the parental Huh-7 cell lysates was used as a negative control (lane 1), and the
purified recombinant His--NS5A (lane 4) was loaded as a positive control. C, cross-
linking to the HCV genome. Biotinylated HCV replicon RNA (2 g) was incubated with
125 g of cell lysate. Cross-linking was performed by adding 1% formaldehyde for 15
min and then quenched by adding glycine (0.25 M final concentrations). Streptavidin
beads (50 l) were added to pull down the RNA-protein complex. The samples were
heated in 1 SDS sample buffer and analyzed by 8% SDS-PAGE and Western blotting.
NS5A was detected when S2204I replicon cell lysate was incubated with the biotinylated
HCV RNA, cross-linked, pulled down, stringently washed (SW), and treated with RNase A
(lane 2). NS5A was also detected when S2204I replicon cell lysates were incubated with
the biotinylated HCV RNA and pulled down (lane 3). Very little, if any, NS5A was detected
when S2204I replicon cell lysate was incubated with the biotinylated HCV RNA, pulled
down, and stringently washed (lane 4).
FIGURE 10. Phosphorylation sites in the carboxyl terminus of NS5A are not essential
for replication. A, construct of 2380 –2409. In the context of S2204I adaptive mutation,
the third region in NS5A that contains a cluster of conserved serine residues was deleted.
B, 2380 –2409 replicates in G418 selection assay. 2 g of in vitro transcribed sub-
genomic replicon RNA was transfected to 1.6  106 Huh-7 cells. 1  105 cells were
seeded in 100-mm diameter dishes and were subjected to G418 selection. The replica-
tion-deficient pol replicon that contains a GDD to GAA mutation in the viral polymerase
did not produce any viable colonies, whereas 2380 –2409 replicon replicated with effi-
ciency similar to the S2204I replicon. C, Western blot analysis of NS5A expressed in the
2380 –2409 replicon cells. Proteins from Huh-7 cells that stably supported S2204I or
2380 –2409 replicon were separated on an 8% SDS-polyacrylamide gel and were
probed with a rabbit anti-NS5A polyclonal antibody. Purified recombinant NS5A and the
parental Huh-7 cells were used as positive and negative controls. D, metabolic labeling of
S2204I and 2380 –2409 replicon cells. Parental Huh-7 cells, SI replicon cells, and 2380 –
2409 replicon cells were incubated with 35S-protein labeling mix (left) or [32P]orthophos-
phate (right) in Dulbecco’s modified Eagle’s medium for 18 h. After lysis, NS5A was immu-
noprecipitated with a rabbit anti-NS5A antibody. Immunoprecipitates were separated
on 8% SDS-polyacrylamide gels and visualized by PhosphorImaging.
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procedure to express and purify NS5A from the soluble fraction of
E. coli (20). During development of the purification protocol, we noted
that nucleic acid in the cell extract prevented NS5A from binding to
several chromatographic resins. This observation suggested the possi-
bility that NS5A was a nucleic acid-binding protein.
Our initial experiments showed that purified NS5A (Fig. 2) had the
capacity to bind to HCV subgenomic replicon RNA with an affinity in
the micromolar range (Fig. 3). At least one region of this RNA that was
bound byNS5Awas the 3-NTR (Fig. 4), and high affinity binding to this
RNA required the polypyrimidine tract. NS5A also had the capacity to
bind the 3-end of HCVminus strand RNA (referred to as 3-TR in Fig.
4). In order to define the specificity of binding, we evaluated the capacity
of NS5A to bind to a variety of single- and double-stranded RNA and
DNA oligonucleotides (TABLE ONE). NS5A had a clear preference for
U-rich andG-richRNA (TABLEONE). This preferencewas scrutinized
further by using a variety of approaches, including a competition filter
binding assay (Fig. 5), UV cross-linking (Fig. 6), and fluorescence polar-
ization (Fig. 7). Most interestingly, NS5A interacts with both the base
and the sugar moieties of nucleic acid as the affinity of NS5A for rU15
was much greater than for dU15, and no detectable binding to dT15 was
observed (Fig. 5). More importantly, HCV NS5A present in cell-free
extracts prepared fromHuh-7 cells stably replicating HCV subgenomic
RNA was also capable of binding to a synthetic RNA oligonucleotide
and full-length HCV genomic RNA (Fig. 9), suggesting that RNA bind-
ing activity of NS5A is retained in a cellular milieu in the presence of the
other nonstructural proteins.
Putative NS5A-binding Sites in the 5- and 3-Ends of HCV Plus and
Minus StrandRNA—Given the observed preference ofNS5A forU- and
G-rich RNA, we asked whether elements of the appropriate composi-
tion existed in either the 3-NTR or 3-TR. The polypyrimidine tract is
the primary location for high affinity NS5A-binding sites in the 3-NTR
(Fig. 11A). U/G stretches exist in every stable stem of the 3-TR (Fig.
11B). In addition, U/G stretches also exist in the 5-NTR, and many of
these tracts are in elements known to contribute to the internal ribo-
some entry site (IRES) (Fig. 11C).
The polypyrimidine tract in the 3-NTR is absolutely essential for
genome replication and virus viability (9, 10, 30). Efficient genome rep-
lication is observed when only 26 uridylate residues are present in this
region of the genome (9). Most interestingly, a genome containing only
six uridylate residues is quasi-replication-competent as replication-
competent revertants can be obtained (9). In contrast, a genome con-
taining only a single uridylate residue is lethal for genome replication
(9). These data, combined with the observation that the polypyrimidine
tract is the site for NS5A binding to the 3-NTR, suggest that binding of
NS5A to the 3-NTRmay be necessary for efficient RNA synthesis. This
possibility does not exclude a role for cellular proteins binding to the
polypyrimidine tract (33). Indeed, the 3-NTR has been suggested to be
important for translation (34), although a role for the polypyrimidine
tract in translation is unlikely (10).
Sites other than the 3-NTR are utilized by NS5A. The quantity of
NS5A recovered from an RNA pull-down experiment was unchanged
by deleting the 3-NTR from HCV RNA (Fig. 9B). This observation
confirms the existence of low affinity binding sites in the HCV genome
and the capacity for NS5A to act as a nonspecific RNA-binding protein.
Of course, the number of nonspecific sites greatly exceeds the number
of specific sites. As discussed in greater detail below, the function of this
nonspecific RNAbinding activity could be to reduce the level of second-
ary structure present in the genome.
The 3-TR is also assumed to be essential for genome replication.
Clearly, production of full-length plus strand RNA requires initiation at
the 3-end of the minus strand, so the complex secondary structure
associatedwith this cis-acting replication element has been suggested to
function in replicase assembly (35). In the 3-TR, single-stranded U/G
stretches are not predicted to exist in the most thermodynamically sta-
ble form of the RNA (Fig. 11B). This prediction provides an explanation
for the reduced end point observed for binding of NS5A to this RNA
(Fig. 4). It is possible that a fraction of the RNA was trapped in a mis-
folded conformation, exposing U/G-rich elements that could be bound
by NS5A. Alternatively, given the intrinsic dynamics (breathing) of
nucleic acid duplexes (36, 37), it is possible that NS5A was capable of
trapping open regions of the appropriate sequence composition when
present in the single-stranded conformation.
TheHCV 5-NTR is absolutely essential for HCVmultiplication (38).
The 5-NTR can be divided into three domains, I–III. Domain I is
required for genome replication (38). Domains II and III form the IRES
that is required for production of the HCV polyprotein (38). Domains II
and III form a tertiary structure (39, 40) that facilitates interaction with
the 40 S ribosomal subunit (41), and this binary complex then recruits
eIF3 to form a 43 S preinitiation complex (39). Interactions between the
IRES and 40 S ribosomal subunit are mediated by the interaction of
ribosomal proteins withmost of the accessible surface of domains II and
III. The interaction between eIF3 and domain III is restricted to the
bulge in stem IIIb (Fig. 11C). At least one potential site forNS5Abinding
to the 5-NTR is present in each of the three domains, with the highest
frequency of sites located in domain III (Fig. 11C). Particularly intrigu-
ing is the presence of a binding site in the domain IIId loop. This loop is
absolutely essential for 40 S ribosome binding, and antisense oligonu-
cleotides directed to this loop inhibit 40 S ribosomal subunit binding
and translation (42).
Functional Implications for the Interaction betweenNS5Aand 5- and
3-Ends of HCV Plus andMinus Strand RNA—One of themost obvious
functions for binding sites in the 3-end of plus andminus strand RNAs
is recruitment of replicase components to the appropriate RNA. NS5A
is known to interact with NS5B (15, 24), and NS5B interacts with NS3-
4A, the viral helicase (15, 25). However, once assembled, the presence of
a single-stranded RNA-binding protein with even low affinity for RNA
could help to stabilize single-stranded RNA intermediates produced by
the helicase, for example in the 3-TR, and to increase the efficiency of
replication by the polymerase by diminishing the level of secondary
structure. In fact, given the substantial accumulation of NS5A in cells
persistently replicating HCV RNA (43), too high of an affinity for RNA
could inhibit translation of cellular and viral mRNA and genome
replication.
A function for NS5A binding to the IRES and the 3-NTR of HCV
RNA could be to cause the switch from translation of the genome to
replication of the genome. It is well documented that RNA templates for
translation in eukaryotes are functionally circular because of interac-
tions between proteins bound to the 5- and 3-ends of the RNA. Viral
RNAs are likely no different (44). Whereas the 40 S subunit and eIF3
bind to the HCV IRES, many cellular proteins have been implicated in
binding to the 3-NTR. Whether or not proteins bound to the 3-NTR
participate in translation or genome circularization is not known. How-
ever, it is safe to assume that these proteins need to be displaced in order
for genome replication to occur. NS5A binding to subdomain IIId of the
IRES could prevent ribosome binding, and preinitiation complex for-
mation and binding to the polyuridine tract could provide a steric block
to formation of protein-bridged interactions between the 5- and
3-NTRs. Although it is not absolutely clear whether circularization of
the HCV genome is required for genome replication, the possibility has
been suggested (45). This level of organization of the genome could be
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mediated by interaction between NS5A proteins bound to the 5- and
3-NTRs. Alternatively, NS5A bound to the 5-NTR could interact with
NS5B bound to the 3-NTR.
Role of Phosphorylation—NS5A can be phosphorylated in mam-
malian cells (17). It is generally assumed that all of the NS5A in cells
is phosphorylated because the protein migrates in SDS-polyacryl-
amide gels as 56–58-kDa species instead of the expected 49-kDa
species. However, we have shown that unphosphorylated, untagged
NS5A co-migrates with the 56-kDa form produced in Huh-7 cells
(20). Therefore, it was possible that unphosphorylated protein is
present in the cell. The existence of unphosphorylated NS5A in
Huh-7 cells was confirmed by using two-dimensional gel electro-
phoresis andWestern blotting to evaluate extracts prepared for cells
stably replicating an HCV subgenomic replicon (Fig. 8). RNA immu-
noprecipitation experiments were used to show that NS5A protein
produced in the replicon cells is capable of binding to RNA (Fig. 9).
However, more studies will be required to determine whether this
binding was due to unphosphorylated protein, phosphorylated pro-
tein, or both.
Three potential clusters of phosphorylation exist (Fig. 1). Cluster II
contains, at best, a single conserved site of phosphorylation. In contrast,
cluster III has multiple phosphorylation sites and is the primary reason
thatNS5A can bemetabolically labeledwith orthophosphate (Fig. 10D).
Cluster III can be deleted without any impact on the RNA binding
FIGURE 11. Potential NS5A-binding sites in HCV RNA. Highlighted in red are G/U stretches observed in ()3-NTR (A), ()3-TR (B), and ()5-NTR of HCV RNA (C).
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activity of NS5A,3 and these same deletions support genome replication
in Huh-7 cells (Fig. 10B). The role of cluster I is not as straightforward.
This region is absolutely required for genome replication and is the site
of mutations that permit HCV genomes to replicate in Huh-7 cells (6).
Again, preliminary studies suggest theNS5Aderivativeswith changes in
cluster I retain RNA binding activity. Because NS5A phosphorylation is
not essential for RNA binding, it is possible that NS5A phosphorylation
provides a mechanism to activate cryptic functions of NS5A, for exam-
ple by regulating the interferon-induced, double-stranded RNA-acti-
vated protein kinase or interacting with proteins involved in cellular
signaling pathways. Notwithstanding, phosphorylation may alter the
specificity or affinity of NS5A for RNA. Additional studies will be
required to address these possibilities directly.
Cellular Proteins with Comparable Specificity—The sequence of
NS5A lacks any motifs consistent with the RNA binding activity of
the protein. Actually, this circumstance is not completely unex-
pected for two reasons. First, many RNA-binding motifs, for exam-
ple the RNA recognition motif, are based on the tertiary fold and
often lack sequence similarity (46). Second, many of the sequence-
specific interactions of proteins with RNA employ the carbonyl and
amide moieties of the backbone rather than the side chains of amino
acids, thus providing an explanation for minimal sequence similar-
ity, if any (46).
Because we could not use the NS5A sequence to gain insight into
NS5A structure or function, we asked whether the NS5A binding spec-
ificity was unique. If proteins of known structure and function with
similar binding specificity exist, then these proteins may represent use-
ful starting points for development of a structural model for NS5A and
provide additional clues into possible virus-host interaction functions
for NS5A. Several cellular proteins with specificity essentially identical
to that of NS5A, i.e. capable of binding to poly(rU) and/or poly(rG) but
incapable of binding to poly(rC) or poly(rA), were identified: lupus anti-
gen (47, 48), cleavage and stimulation factor 64 (49), TIA-1 (50), sex-
lethal protein (Sxl) (51),Trypanosoma cruziRNA-binding proteins (52),
and fragile X mental retardation protein (53). With the exception of
fragile X mental retardation protein, which has a KH (hnRNA
homology) domain, all of these proteins contain one or more RNA
recognition motifs. Most of these proteins exist in the cytoplasm, at
least occasionally, and in this compartment, these proteins function
as post-transcriptional regulators of gene expression (48, 50, 52, 53).
Some of these proteins also exist occasionally in the nucleus, for
example Sxl and TIA-1, and in this compartment, these proteins
function as splicing regulators. Most interestingly, lupus antigen
binds to both the 5- and 3-NTRs of HCV RNA (54, 55).
Recently, it has become clear that the amino-terminal domain of
NS5A binds zinc (56) by using a new zinc coordination motif in the
context of a novel fold (57). This domain crystallized as a dimer. A
groove exists at the interface of the two molecules that has a positive
electrostatic potential with dimensions appropriate for binding to sin-
gle-stranded RNA (57). Therefore, NS5A may define a novel structural
class of RNA-binding proteins.
In conclusion, the finding thatHCVNS5A is anRNA-binding protein
provides the second activity of this protein with implications for
genome replication and represents another functional target for the
development of anti-HCV therapeutics. The capacity of cellular
pre-mRNA splicing, mRNA stability, and translation to be regulated by
proteins with binding specificities identical to that of NS5A begs the
question: does NS5A employ these activities as well?
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